| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 397-401 |
| Journal | Journal of Nuclear Medicine |
| Volume | 54 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2013 |
Cite this
}
Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients. / Heuveling, D.A.; de Bree, R.; Vugts, D.J.; Huisman, M.C.; Giovannoni, L.; Hoekstra, O.S.; Leemans, C.R.; Neri, D.; van Dongen, G.A.M.S.
In: Journal of Nuclear Medicine, Vol. 54, No. 3, 2013, p. 397-401.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients
AU - Heuveling, D.A.
AU - de Bree, R.
AU - Vugts, D.J.
AU - Huisman, M.C.
AU - Giovannoni, L.
AU - Hoekstra, O.S.
AU - Leemans, C.R.
AU - Neri, D.
AU - van Dongen, G.A.M.S.
PY - 2013
Y1 - 2013
U2 - 10.2967/jnumed.112.111310
DO - 10.2967/jnumed.112.111310
M3 - Article
VL - 54
SP - 397
EP - 401
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
SN - 0161-5505
IS - 3
ER -